Abstract:Summary Background Global dissemination of SARS-CoV-2 Omicron sublineages has provided a sufficient opportunity for natural selection, thus enabling beneficial mutations to emerge. Characterisation of these mutations uncovers the underlying machinery responsible for the fast transmission of Omicron variants and guides vaccine development for combating the COVID-19 pandemic. Methods Through systematic bioinformatics analysis of 496,606 sequences of Omicron variants, we obtained 40 amino acid substitutions that occurred with high frequency in the S protein. Utilising pseudoviruses and a trans -complementation system of SARS-CoV-2, we identified the effect of high-frequency mutations on viral infectivity and elucidated the molecular mechanisms. Finally, we evaluated the impact of a key emerging mutation on the immune protection induced by the SARS-CoV-2 VLP mRNA vaccine in a murine model. Findings We identified a proline-to-leucine substitution at the 1263rd residue of the Spike protein, and upon investigating the relative frequencies across multiple Omicron sublineages, we found a trend of increasing frequency for P1263L. The substitution significantly enhances the capacity for S-mediated viral entry and improves the immunogenicity of a virus-like particle mRNA vaccine. Mechanistic studies showed that this mutation is located in the FERM binding motif of the cytoplasmic tail and impairs the interaction between the S protein and the Ezrin/Radixin/Moesin proteins. Additionally, this mutation facilitates the incorporation of S proteins into SARS-CoV-2 virions. Interpretation This study offers mechanistic insight into the constantly increasing transmissibility of SARS-CoV-2 Omicron variants and provides a meaningful optimisation strategy for vaccine development against SARS-CoV-2. Funding This study was supported by grants from the National Key Research and Development Plan of China ( 2021YFC2302405 , 2022YFC2303200 , 2021YFC2300200 and 2022YFC2303400 ), the National Natural Science Foundation of China ( 32188101 , 32200772 , 82422049 , 82241082 , 32270182 , 82372254 , 82271872 , 82341046 , 32100755 and 82102389 ), Shenzhen Medical Research Fund ( B2404002 , A2303036 ), the Shenzhen Bay Laboratory Startup Fund ( 21330111 ), Shenzhen San-Ming Project for Prevention and Research on Vector-borne Diseases ( SZSM202211023 ), Yunnan Provincial Science and Technology Project at Southwest United Graduate School ( 202302AO370010 ). The New Cornerstone Science Foundation through the New Cornerstone Investigator Program, and the Xplorer Prize from Tencent Foundation.

The evolution of the mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America

The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development

Review of the mechanisms of SARS-CoV-2 evolution and transmission

Emerging vaccine-breakthrough SARS-CoV-2 variants

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation

Relatively Rapid Evolution Rates of SARS-CoV-2 Spike Gene at the Primary Stage of Massive Vaccination

Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity

Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, South Africa, and other COVID-19-devastated countries

Vaccination shapes evolutionary trajectories of SARS-CoV-2

Immune Evasion and ACE2 Binding Affinity Contribute to SARS-CoV-2 Evolution

Host Immune Response Driving SARS-CoV-2 Evolution

Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion

Mutations of SARS-CoV-2 Spike Protein: Implications on Immune Evasion and Vaccine-Induced Immunity

Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization

Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity

Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in Spike Glycoprotein

A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity

Evolutionary Pattern Comparisons of the SARS-CoV-2 Delta Variant in Countries/Regions with High and Low Vaccine Coverage

Vaccination with Span, an Antigen Guided by SARS-CoV-2 S Protein Evolution, Protects Against Challenge with Viral Variants in Mice.

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape

Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.